NTxBio
PrivateLast Round
Grant
May 14, 2025
Total Funding Raised
$77.32M
Company Overview
NTxBio is a biotechnology company that provides a cell-free biomanufacturing platform for the scalable production of high-quality RNA and protein therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NTxBio Comparables
Compare NTxBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tierra Biosciences | 79% | |
| Liberum Biotech | 79% | |
| GenScript | 73% | |
NTxBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 14, 2025 | ||||
| Debt | Dec 4, 2024 | ||||
| Series B | Nov 16, 2023 | ||||
| Grant | Feb 25, 2020 | ||||
| Series A | Feb 25, 2020 |
NTxBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A, Series B |
| Texas Enterprise Fund | Grant |
| New Mexico Economic Development Department | Grant |
| Anzu Partners | Series B, Series A |
| New Mexico Economic Development Department | Grant |
| BlueStone Venture Partners | Series B |
| JPMorgan Chase & Co. | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2025
Opening a new $31 million facility and adding 170 jobs in Texas.
- May 14, 2025
$1.48M grant from Texas Enterprise Fund
NTxBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NTxBio's valuation, stock price, and market status.